Migraine-Specific Quality-of-Life Questionnaire (MSQ) Version 2.1 Score Improvement in Japanese Patients with Episodic Migraine by Galcanezumab Treatment: Japan Phase 2 Study

PURPOSE: Evaluate changes from baseline in health-related quality of life (QoL) in Japanese patients with episodic migraine receiving preventive treatment with galcanezumab (GMB). PATIENTS AND METHODS: Preventive treatments for migraine have been shown to improve QoL, but few clinical trials have ex...

Descripción completa

Detalles Bibliográficos
Autores principales: Shibata, Mamoru, Nakamura, Tomomi, Ozeki, Akichika, Ueda, Kaname, Nichols, Russell M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781358/
https://www.ncbi.nlm.nih.gov/pubmed/33408512
http://dx.doi.org/10.2147/JPR.S287781

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7781358/
https://www.ncbi.nlm.nih.gov/pubmed/33408512
http://dx.doi.org/10.2147/JPR.S287781

Ejemplares similares